193 related articles for article (PubMed ID: 28637474)
1. Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells.
Yin Q; Sides M; Parsons CH; Flemington EK; Lasky JA
Virol J; 2017 Jun; 14(1):121. PubMed ID: 28637474
[TBL] [Abstract][Full Text] [Related]
2. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
3. Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells.
Zebboudj A; Maroui MA; Dutrieux J; Touil-Boukoffa C; Bourouba M; Chelbi-Alix MK; Nisole S
Biochimie; 2014 Dec; 107 Pt B():247-56. PubMed ID: 25241256
[TBL] [Abstract][Full Text] [Related]
4. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
[TBL] [Abstract][Full Text] [Related]
5. Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes.
Wu CC; Fang CY; Hsu HY; Chen YJ; Chou SP; Huang SY; Cheng YJ; Lin SF; Chang Y; Tsai CH; Chen JY
Antiviral Res; 2016 Aug; 132():99-110. PubMed ID: 27185626
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells.
Liu S; Li H; Chen L; Yang L; Li L; Tao Y; Li W; Li Z; Liu H; Tang M; Bode AM; Dong Z; Cao Y
Carcinogenesis; 2013 Mar; 34(3):627-37. PubMed ID: 23180656
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin enhances lytic replication of Epstein-Barr virus in gastric carcinoma cells by increasing the transcriptional activities of immediate-early lytic promoters.
Wang M; Wu W; Zhang Y; Yao G; Gu B
Virus Res; 2018 Jan; 244():173-180. PubMed ID: 29169830
[TBL] [Abstract][Full Text] [Related]
8. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
Perez-Chacon G; de Los Rios C; Zapata JM
Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
[TBL] [Abstract][Full Text] [Related]
9. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
[TBL] [Abstract][Full Text] [Related]
10. Identification of a new class of small molecules that efficiently reactivate latent Epstein-Barr Virus.
Tikhmyanova N; Schultz DC; Lee T; Salvino JM; Lieberman PM
ACS Chem Biol; 2014 Mar; 9(3):785-95. PubMed ID: 24028149
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide induces programmed cell death through stimulation of ER stress and inhibition of the ubiquitin-proteasome system in human sarcoma cells.
Chiu HW; Tseng YC; Hsu YH; Lin YF; Foo NP; Guo HR; Wang YJ
Cancer Lett; 2015 Jan; 356(2 Pt B):762-72. PubMed ID: 25449439
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin.
Wu CC; Fang CY; Cheng YJ; Hsu HY; Chou SP; Huang SY; Tsai CH; Chen JY
J Biomed Sci; 2017 Jan; 24(1):2. PubMed ID: 28056971
[TBL] [Abstract][Full Text] [Related]
13. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
[TBL] [Abstract][Full Text] [Related]
14. Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine.
Cavaliere V; Lombardo T; Costantino SN; Kornblihtt L; Alvarez EM; Blanco GA
Eur J Cancer; 2014 Dec; 50(18):3243-61. PubMed ID: 25446377
[TBL] [Abstract][Full Text] [Related]
15. A new compound, phomaherbarine A, induces cytolytic reactivation in epstein-barr virus-positive B cell lines.
Bae SE; Choi JW; Hong JW; Ku H; Sim KY; Ko GH; Jang DS; Shim SH; Park SG
Antiviral Res; 2024 Jul; 227():105906. PubMed ID: 38735576
[TBL] [Abstract][Full Text] [Related]
16. Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents.
Ghosh SK; Forman LW; Akinsheye I; Perrine SP; Faller DV
Blood Cells Mol Dis; 2007; 38(1):57-65. PubMed ID: 17161633
[TBL] [Abstract][Full Text] [Related]
17. Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.
Inman GJ; Binné UK; Parker GA; Farrell PJ; Allday MJ
J Virol; 2001 Mar; 75(5):2400-10. PubMed ID: 11160743
[TBL] [Abstract][Full Text] [Related]
18. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
19. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
20. Secreted Oral Epithelial Cell Membrane Vesicles Induce Epstein-Barr Virus Reactivation in Latently Infected B Cells.
Lin Z; Swan K; Zhang X; Cao S; Brett Z; Drury S; Strong MJ; Fewell C; Puetter A; Wang X; Ferris M; Sullivan DE; Li L; Flemington EK
J Virol; 2016 Jan; 90(7):3469-79. PubMed ID: 26764001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]